Ipsoflame en es it fr

Ipsoflame Brand names, Ipsoflame Analogs

Ipsoflame Brand Names Mixture

  • Alka Phenyl Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
  • Alka Phenylbutazone Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
  • Phenylone Plus Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)

Ipsoflame Chemical_Formula


Ipsoflame RX_link

No information avaliable

Ipsoflame fda sheet

Ipsoflame msds (material safety sheet)

Ipsoflame MSDS

Ipsoflame Synthesis Reference

Ullmann's Encyklopaedie der Technischen Chemie 13, 298 (1962)

Ipsoflame Molecular Weight

308.374 g/mol

Ipsoflame Melting Point

105 oC

Ipsoflame H2O Solubility

47.5 mg/L

Ipsoflame State


Ipsoflame LogP


Ipsoflame Dosage Forms

Bolus; Liquid; Paste; Powder; Solution; Tablet

Ipsoflame Indication

For the treatment of backache and ankylosing spondylitis

Ipsoflame Pharmacology

Phenylbutazone is a synthetic, pyrazolone derivative. It is a nonhormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties and arise from its ability to reduce production of prostaglandin H and prostacyclin. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostacylcin causes vascular constriction platelet disaggregation

Ipsoflame Absorption

No information avaliable

Ipsoflame side effects and Toxicity

Oral, LD50 = 238 mg/kg (mouse); Oral, LD50 = 781 mg/kg (rabbit); Oral, LD50 = 245 mg/kg (rat); Oral, LD50 = 375 mg/kg (rat)

Ipsoflame Patient Information

No information avaliable

Ipsoflame Organisms Affected

Humans and other mammals